Yahoo Web Search

  1. Celgene Corporation CELG announced top-line results from the international phase III study, QUAZAR AML-001. The study evaluated the efficacy and safety of investigational CC-486 ...

  2. Celgene (CELG) Gains But Lags Market: What You Should Know

    Zacks via Yahoo FinanceSep 05 21:50 PM

    Celgene (CELG) closed the most recent trading day at $97.43, moving +0.47% from the previous trading session. The stock lagged the S&P 500's daily gain of 1.3%. This has outpaced the ...

  3. This change outpaced the S&P 500's 0.72% gain on the day. This has outpaced the Medical sector's loss of 1.41% and the S&P 500's gain of 2.25% in that time. Meanwhile, the Zacks Consensus Estimate ...

  4. The biotech space saw muted activity in the week ended Aug. 30. Among the notable news of the week: Amgen, Inc. (NASDAQ: AMGN )'s $13.4-billion deal to buy the psoriasis drug Otezla from Celgene Corporation ...

  5. Roche RHHBY announced that it has extended the period of its previously-announced tender offer to purchase the outstanding shares of common stock of Spark Therapeutics for $114.50 per share.

  6. Ardelyx Inc (NASDAQ: ARDX) Avedro Inc (NASDAQ: AVDR) Celgene Corporation (NASDAQ: CELG) Eidos Therapeutics Inc (NASDAQ: EIDX) Enlivex Therapeutics Ltd (NASDAQ: ENLV) The Medicines ...

  7. 5 Cancer-Fighting Stocks to Add to Your Portfolio

    Zacks via Yahoo FinanceSep 03 11:02 AM

    Cancer has become a major health scare in the 21st century, with nearly every individual knowing someone or the other who has been affected. Cancer in layman’s term is a disease that is caused ...

  8. FDA Grants Orphan Drug Status to Acceleron's PAH Candidate

    Zacks via Yahoo FinanceSep 10 22:00 PM

    Acceleron Pharma Inc. XLRN announced that the FDA has granted an orphan drug designation to its investigational candidate sotatercept for the treatment of patients with pulmonary arterial hypertension ...

  9. Alexion (ALXN) In-licenses Amyloidosis Candidate In Japan

    Zacks via Yahoo FinanceSep 10 15:39 PM

    Alexion Pharmaceuticals, Inc. ALXN announced a license agreement with BridgeBio Pharma, Inc.’s BBIO subsidiary Eidos Therapeutics, Inc. EIDX. Per the terms of the deal, Alexion will obtain an ...

  10. Roche Holding AG RHHBY recently announced that the European Commission (EC) has approved and granted marketing authorization to two indications of its immuno-oncology drug, Tecentriq (atezolizumab ...

  1. Ads
    related to CELGENE CORPORATION